Renoprotection by Inhibiting Connexin 43 Expression in a Mouse Model of Obesity-Related Renal Injury
Xiaomin An,Guohua Li,Shu Wang,Tianrun Xie,Xiaoxiao Ren,Yongli Zhao
DOI: https://doi.org/10.2147/DMSO.S412546
2023-05-17
Abstract:Xiaomin An, 1, 2, &ast Guohua Li, 1, &ast Shu Wang, 1 Tianrun Xie, 1 Xiaoxiao Ren, 1 Yongli Zhao 1 1 Department of Pediatrics, The Second Hospital of Dalian Medical University, Dalian, 116027, People's Republic of China; 2 Department of Nephrology, Xi'an Children's Hospital, Xi'an, 710003, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yongli Zhao, Department of Pediatrics, The Second Hospital of Dalian Medical University, Dalian, 116027, People's Republic of China, Tel +86 0411 84671291, Email Introduction: Our previous study conducted in an obesity-related renal injury rat model have established a connection between increased connexin 43 (Cx43) expression and renal injury. In this study, we investigated whether inhibiting Cx43 expression could provide renoprotection in a mouse model of obesity-related renal injury. Methods: Five-week-old C57BL/6J mice were fed with a high-fat diet for 12 weeks to establish an obesity-related renal injury model, then they were treated with Cx43 antisense oligodeoxynucleotide (AS) or scrambled oligodeoxynucleotide (SCR) by an implanted osmotic pump for 4 weeks. Finally, the glomerular filtration function, the histological change in the glomeruli, and the markers of podocyte injury (WT-1, Nephrin) and inflammatory infiltration of renal tissue (CD68, F4/80 and VCAM-1) were examined respectively. Results: The results showed that inhibiting Cx43 expression by AS in this mouse model of obesity-related renal injury can effectively improve glomerular filtration function, alleviate glomerular expansion and podocyte injury, and attenuate the inflammatory infiltration of renal tissue. Conclusion: Our results demonstrated that inhibiting Cx43 expression by AS could provide renoprotection for the mouse model of obesity-related renal injury. Keywords: childhood obesity, obesity-related renal injury, connexin 43, antisense oligodeoxynucleotide Obesity has many impacts on children's health, which could lead to various metabolic disorders and increase the risks of diabetes, cardiovascular diseases, renal injury, and chronic kidney diseases in their adulthood, 1 and the potential pathogenic mechanisms include chronic metabolic inflammation, oxidative stress, insulin resistance and others. It has been reported that microalbuminuria is the early clinical manifestation of obesity-related renal injury in children. 2 The main pathological manifestations of obesity-related renal injury include glomerular hypertrophy and mesangial expansion with or without segmental sclerosis. 3 The main ultrastructural pathological changes in the early stage include reduced numbers of podocytes, foot process fusion, and effacement, 4 which is the main reason for the microalbuminuria. 5 Connexin 43 (Cx43) is a subtype of the gap junction proteins of connexins, 6 which is widely distributed in renal tissue, 7,8 and has a critical role in maintaining normal glomerular filtration. 7,8 In pathological situations, the alteration of Cx43 expression is related to renal injury. 9,10 Our previous work carried out in an obesity-related renal injury model revealed that the increased Cx43 expression was connected to renal injury, which included glomerular expansion, podocyte foot process effacement, and other molecular pathological changes. 11 Until now, it is unclear whether inhibiting Cx43 expression could provide renoprotection in the obesity-related renal injury model. In this study, the Cx43 antisense oligodeoxynucleotide (AS) was used to reduce Cx43 expression in a mouse model of obesity-related renal injury, and then we investigated whether inhibiting Cx43 expression could provide renoprotection in this mouse model. All animal experiments were approved by the Ethical Committee of the Second Hospital of Dalian Medical University. All animal experiments were carried out in compliance with the NIH guidelines for the care and use of laboratory animals (8th edition, NIH, 2011). All methods were carried out under relevant guidelines and regulations. Four-week-old male C57BL/6J mice (n=48) were purchased from the Laboratory Animal Center of Dalian Medical University. Animals were housed doubly with a 12-h light-dark cycle by artificial light and at a constant room temperature of 20–22°C. All animals had free access to food and water. All mice were allowed to acclimate a new environment for 1 week, and then randomly divided into two groups: the control (Con) group and the obesity-related renal injury (ORI) group. The control group was fed a normal-fat diet (10% kcal f -Abstract Truncated-
endocrinology & metabolism